Tidal Investments LLC raised its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 19.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,525 shares of the company's stock after buying an additional 1,408 shares during the period. Tidal Investments LLC's holdings in Molina Healthcare were worth $2,481,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in MOH. Norges Bank bought a new position in shares of Molina Healthcare in the 4th quarter worth $134,675,000. FMR LLC grew its holdings in shares of Molina Healthcare by 31.1% during the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after purchasing an additional 427,276 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Molina Healthcare by 28.5% during the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock valued at $386,229,000 after purchasing an additional 294,180 shares during the last quarter. Wellington Management Group LLP grew its holdings in shares of Molina Healthcare by 7.4% during the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after purchasing an additional 181,073 shares during the last quarter. Finally, Los Angeles Capital Management LLC grew its holdings in shares of Molina Healthcare by 166.1% during the 4th quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company's stock valued at $57,195,000 after purchasing an additional 122,674 shares during the last quarter. Institutional investors own 98.50% of the company's stock.
Insider Transactions at Molina Healthcare
In related news, CEO Joseph M. Zubretsky sold 87,500 shares of Molina Healthcare stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the transaction, the chief executive officer now directly owns 257,715 shares of the company's stock, valued at $82,484,262.90. This trade represents a 25.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the transaction, the director now directly owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. This trade represents a 5.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 89,169 shares of company stock valued at $28,520,995. Company insiders own 1.10% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on MOH shares. Guggenheim started coverage on shares of Molina Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating on the stock. Wall Street Zen raised shares of Molina Healthcare from a "hold" rating to a "buy" rating in a report on Friday, April 11th. Robert W. Baird reaffirmed a "neutral" rating and set a $375.00 target price (up previously from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Wells Fargo & Company raised shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and increased their target price for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. Finally, Stephens reissued an "equal weight" rating and issued a $345.00 price target on shares of Molina Healthcare in a report on Thursday, February 6th. Nine research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $365.38.
View Our Latest Report on MOH
Molina Healthcare Trading Up 0.7%
Shares of NYSE:MOH traded up $2.01 on Tuesday, hitting $307.24. The company had a trading volume of 176,966 shares, compared to its average volume of 691,776. The firm's 50-day simple moving average is $324.25 and its two-hundred day simple moving average is $307.58. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $365.23. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $16.65 billion, a price-to-earnings ratio of 15.02, a P/E/G ratio of 1.06 and a beta of 0.63.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The firm had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. During the same period last year, the company posted $5.73 EPS. The company's quarterly revenue was up 12.2% compared to the same quarter last year. Equities analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Further Reading

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.